BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bioinformatics Software | QIAGEN Digital Insights - ECPv6.15.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bioinformatics Software | QIAGEN Digital Insights
X-ORIGINAL-URL:https://staging.digitalinsights.supremeclients.com
X-WR-CALDESC:Events for Bioinformatics Software | QIAGEN Digital Insights
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20210101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20230504T110000
DTEND;TZID=UTC:20230504T120000
DTSTAMP:20260404T041930
CREATED:20230329T123527Z
LAST-MODIFIED:20241024T182853Z
UID:10000628-1683198000-1683201600@staging.digitalinsights.supremeclients.com
SUMMARY:Como anotar variantes somáticas e avaliar a prevalência delas com um único banco de dados
DESCRIPTION:Dentro das aplicações oncológicas\, a habilidade de identificar alterações genéticas potencialmente acionáveis e explorar as vulnerabilidades moleculares do câncer está se tornando cada vez mais difícil. \nUm novo banco de dados desenvolvido pela QIAGEN\, o HSMD\, contém mais de 2 décadas de conteúdo com curadoria especializada e dados da QIAGEN Knowledge Base com mais de 300.000 casos oncológicos de mundo real para fornecer um entendimento profundo e preciso da acionabilidade de variantes pequenas\, tais como SNVs\, indels e frameshifts\, que têm sido “observadas clinicamente” ou consideradas pela literatura científica. \nNo dia 4 de maio\, junte-se a nossos especialistas para um tour virtual do novo banco de dados e apresentação dos seus recursos\, capacidades e aplicações.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/como-anotar-variantes-somaticas-e-avaliar-a-prevalencia-delas-com-um-unico-banco-de-dados/
LOCATION:Virtual - Portugal\, Portugal
CATEGORIES:Clinical,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230427T130000
DTEND;TZID=UTC:20230427T143000
DTSTAMP:20260404T041930
CREATED:20230316T151730Z
LAST-MODIFIED:20241024T182849Z
UID:10000621-1682600400-1682605800@staging.digitalinsights.supremeclients.com
SUMMARY:QIAGEN Ingenuity Pathway Analysis (IPA) for grant writing and publications with new features
DESCRIPTION:QIAGEN Ingenuity Pathway Analysis (IPA) represents a robust resource to aid in the process of writing grants publications. Driven by a wealth of manually-curated molecular interactions and associations in the QIAGEN Knowledge Base together with pre-analyzed public ‘omics data for hundreds of thousands of samples from QIAGEN OmicSoft Lands\, IPA provides biological insights regardless of whether you have your own data or not. In the absence of your own data\, IPA provides a resource to query existing molecular knowledge from the literature or public ‘omics data\, build networks in silico\, and review results from pre-analyzed public studies. With data\, you can dig deeply into the biological meaning of your results through the identification of key pathways\, regulatory molecules and functional changes as well as understand how your study relates to other published studies. \nJoin us for a 90-min training session where you will learn: \n• Ways to query IPA’s vast collection of curated literature and ‘omics data\n• How molecules relate to phenotypes and functions\n• Build your own networks and predict activity changes\n• Ways to explore a library of over 100\,000 precomputed IPA analyses pulled from public ‘omics data\n• How to format your dataset and set up an analysis\n• How to deeply interrogate key Canonical Pathway\n• How to predict regulators which are causing your expression changes\n• How to contextualize the result of your analysis by comparing your results to internal and public data\n• Ways to generate the necessary tables and figures for your manuscript
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/qiagen-ingenuity-pathway-analysis-ipa-for-grant-writing-and-publications-with-new-features/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230427T100000
DTEND;TZID=UTC:20230427T120000
DTSTAMP:20260404T041930
CREATED:20230329T121854Z
LAST-MODIFIED:20241024T182850Z
UID:10000625-1682589600-1682596800@staging.digitalinsights.supremeclients.com
SUMMARY:How to improve your existing pipeline for somatic mutation analysis\, interpretation and reporting: Part 1
DESCRIPTION:We are excited to bring thought leaders\, NGS experts\, lab directors\, variant scientists\, clinicians\, and oncologists under one virtual roof at our second annual Clinical Oncology Summit hosted on April 27 and May 18\, 2023. \nThe two-part\, content-rich event will feature invited lectures from lab directors and clinical geneticists\, thought-provoking discussions on the future of comprehensive genomic profiling\, and educational presentations on the latest databases\, software\, and services for somatic secondary and tertiary analysis. Designed to help clinical diagnostic labs understand how they can optimize their current pipelines for somatic NGS analysis\, interpretation and reporting\, the Clinical Oncology Summit is a must-attend event for labs who need to reduce turnaround time\, improve operational costs\, and scale for higher throughput. \nMeet the speakers and view the full agenda here.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/how-to-improve-your-existing-pipeline-for-somatic-mutation-analysis-interpretation-and-reporting-part-1/
CATEGORIES:Clinical,Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230425T130000
DTEND;TZID=UTC:20230425T143000
DTSTAMP:20260404T041930
CREATED:20230315T134937Z
LAST-MODIFIED:20241024T182848Z
UID:10000620-1682427600-1682433000@staging.digitalinsights.supremeclients.com
SUMMARY:Proteomics and phosphoproteomics data interpretation using QIAGEN Ingenuity Pathway Analysis
DESCRIPTION:In this live QIAGEN Ingenuity Pathway Analysis (IPA) training\, we’ll focus on interpreting proteomics and phosphoproteomics datasets. \nIn this tutorial\, we’ll guide you through steps and workflows to address your questions related to interpreting proteomics and phosphoproteomics datasets using QIAGEN IPA\, such as:\n• How should I format the data before uploading to IPA?\n• How do I set up the analysis?\n• Which upstream kinases are implicated in the observed phosphoproteomics changes?\n• What are the targets of a particular upstream kinase and how do their levels of phosphorylation change over the time course?\n• What are the targets on a particular Canonical Pathway and how do their levels of phosphorylation change over time?\n• Which biological predictions trend in a time-dependent manner during the time course?\n• How do the biological predictions from phosphoproteomics compare with a related transcriptomics dataset? \nAdditional QIAGEN Digital Insights (QDI) scientists will be on the call to answer questions and help with other inquiries\, such as how to install the software\, etc. \nFor those with a QIAGEN IPA license\n• To install IPA before or after the training\, please use the below installer.\nhttps://qiagen.showpad.com/share/CBv30blCPKFDUYHRWtAvI\n• If you haven’t done core analysis in IPA before\, we recommend you review below video/slides before the training (however\, this is not required).\no IPA beginner training recording: https://qiagen.showpad.com/share/t2cGMdF3NjVucBA0b9tIT \no IPA step-by-step guide w/ data format (slide 9) and upload (slide 28) instructions: https://qiagen.showpad.com/share/VjizSLJVBw1qfV
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/proteomics-and-phosphoproteomics-data-interpretation-using-qiagen-ingenuity-pathway-analysis/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230419T110000
DTEND;TZID=UTC:20230419T120000
DTSTAMP:20260404T041930
CREATED:20230317T121304Z
LAST-MODIFIED:20241024T182849Z
UID:10000622-1681902000-1681905600@staging.digitalinsights.supremeclients.com
SUMMARY:Shed light on inherited mutations and solve hereditary investigations with QCI Interpret
DESCRIPTION:In this webinar\, we will demonstrate how QCI Interpret can improve your diagnostic yield for hereditary disorders. QCI Interpret is a clinical decision support platform that leverages augmented molecular intelligence to streamline the interpretation workflow. It uses the most extensive\, globally trusted and manually curated molecular knowledge and bibliography evidence to provide you with the best possible opportunity to solve every case. By demonstrating the different features and series of use-cases\, we will show you how QCI Interpret guarantees a comprehensive and thorough investigation of every case for all types of genetic variation\, including copy number variants (CNVs). This will allow you to provide precise answers to patients and their families\, while also reducing test turnaround time from hours to minutes. \nLearning objectives: \n\nLearn about QCI Interpret’s analysis and interpretation workflow for hereditary diseases using targeted and extended gene panels\, including WES/WGS\nLearn about QCI Interpret and QIAGEN’s expert curation process based on the latest ACMG carrier screening guidelines\nView demonstrations of unique features in QCI Interpret\, including how to input symptoms relevant to a case and receive relationships to candidate diseases and mutated genes using the Phenotype Network Analysis feature and triage mode of variant assessment.\nLearn how QCI Interpret supports CNV interpretation and reporting with bibliographic coverage of over 60\,000 CNV case reports"
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/shed-light-on-inherited-mutations-and-solve-hereditary-investigations-with-qci-interpret/
CATEGORIES:Clinical,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/WEBINAR_QCI_RockReleaseWebinar_0323_16x9.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230418T130000
DTEND;TZID=UTC:20230418T143000
DTSTAMP:20260404T041930
CREATED:20230315T134308Z
LAST-MODIFIED:20241024T182848Z
UID:10000619-1681822800-1681828200@staging.digitalinsights.supremeclients.com
SUMMARY:Public single-cell RNA-seq data investigation using QIAGEN OmicSoft and Ingenuity Pathway Analysis
DESCRIPTION:Single-cell RNA-sequencing (scRNA-seq) is widely used to investigate tissue heterogeneity\, identify novel cell types\, study pathogenic mechanisms\, develop targeted therapy (including immunotherapy) and more. Accordingly\, a tremendous amount of scRNA-seq data has been deposited to public domains like GEO. \nIn this training\, you will learn how to \n· Locate public single-cell studies of interest using QIAGEN Omicsoft Single Cell Lands \n· Study different cell types by dimension reduction plots (for example\, t-SNE\, UMAP) \n· Investigate expression of genes of interest across different cell types (Violin plots\, overlay expression on cluster) \n· Identify key pathways and regulators from scRNA-seq data using QIAGEN Ingenuity Pathway Analysis (IPA)
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/public-single-cell-rna-seq-data-investigation-using-qiagen-omicsoft-and-ingenuity-pathway-analysis/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230413T130000
DTEND;TZID=UTC:20230413T143000
DTSTAMP:20260404T041930
CREATED:20230315T134055Z
LAST-MODIFIED:20241024T182848Z
UID:10000618-1681390800-1681396200@staging.digitalinsights.supremeclients.com
SUMMARY:Make discoveries from public data (GEO\, SRA and more) using QIAGEN Ingenuity Pathway Analysis
DESCRIPTION:You asked for it\, and we’re here to deliver. We are hosting a comprehensive training on effectively using sample-level public data and metadata from sources like GEO\, SRA\, TCGA\, GTEx\, Blueprint\, CCLE and others through QIAGEN Ingenuity Pathway Analysis (IPA) and the IPA Analysis Match Explorer feature. We’ll walk you through use cases involving biomarker discovery\, drug target investigation\, studying survival in custom patient cohorts\, multi-gene correlation and more. \nWe’ll cover topics like:\n• How is a gene of interest expressed across different conditions?(‘conditions’ refers to diseases\, disease subtypes\, treatments\, cell types\, cell lines and more)\n• Is there a correlation in expression for two genes or biomarkers of user interest for a given condition?\n• Can we compare more than two genes in a heatmap?\n• For a given condition of interest\, can we derive a list of genes (for example\, genes specific to a disease\, treatment or cell type)?\n• Can we generate custom cohorts of patients (for example\, TP53 wt vs. mutant or PDCD1 high vs. low expression) and then create survival curves representing those cohorts? Can we generate a p-value to see if there is a significant difference?\n• Can we detect the expression of a gene in different cell types from single-cell data?
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/make-discoveries-from-public-data-geo-sra-and-more-using-qiagen-ingenuity-pathway-analysis/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230413T110000
DTEND;TZID=UTC:20230413T120000
DTSTAMP:20260404T041930
CREATED:20230329T120940Z
LAST-MODIFIED:20241024T182850Z
UID:10000624-1681383600-1681387200@staging.digitalinsights.supremeclients.com
SUMMARY:Take your genome research to the next level with QCI Interpret Translational
DESCRIPTION:Learn how QCI Interpret Translational can get your research to the next level by providing you all the necessary analysis tools with the world’s most comprehensive and up-to-date curated scientific evidence. Get valuable and reliable insights for your research project and speed up your discoveries by using a streamlined NGS analysis workflow in a user-friendly interface without needing bioinformatics expertise. \nIn this webinar\, attendees will have the opportunity to: \n\nExplore capabilities which can enable them to accelerate discoveries from hereditary or tumor cohort analyses\nDiscover interactive tools with current and comprehensive associations between gene variants and diseases\nLearn how these resources are supported by unique curated content among other integrated scientific evidence
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/take-your-genome-research-to-the-next-level-with-qci-interpret-translational/
CATEGORIES:Clinical,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230411T130000
DTEND;TZID=UTC:20230411T143000
DTSTAMP:20260404T041930
CREATED:20230315T133702Z
LAST-MODIFIED:20241024T182846Z
UID:10000617-1681218000-1681223400@staging.digitalinsights.supremeclients.com
SUMMARY:Pathogen detection in wastewater samples using QIAGEN CLC Genomics Workbench
DESCRIPTION:In this 90-minute training\, you will learn how to easily analyze wastewater samples to detect pathogens (SARS-COV2\, etc.) using QIAGEN CLC Genomics Workbench software. \nYou will learn how to:\n• Importing reads\n• Open and modify prebuilt workflow (analysis pipeline)\n• Install and execute workflow\n• Review QC reports\n• Perform genome visualization\n• Export the consensus sequence in FASTA format to upload to Pangolin\n• Create a SNP tree of the consensus sequence and overlay Pangolin information\n• Export graphical and tabular results
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/pathogen-detection-in-wastewater-samples-using-qiagen-clc-genomics-workbench/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230405T110000
DTEND;TZID=UTC:20230405T120000
DTSTAMP:20260404T041930
CREATED:20230329T120420Z
LAST-MODIFIED:20241024T182849Z
UID:10000623-1680692400-1680696000@staging.digitalinsights.supremeclients.com
SUMMARY:Can you trust AI for germline variant curation? A Stanford University case study
DESCRIPTION:In this webinar\, we examine a new study by Stanford University that analyzes the accuracy\, consistency\, and comprehensiveness of automated and manual germline variant curation. The study compares the quality of data from Stanford’s Automatic VAriant evidence DAtabase (AVADA) to the Human Gene Mutation Database (HGMD)\, an expert-curated resource for human inherited disease mutations. \nBy attending this webinar\, you will: \n\nAnalyze a series of use-cases comparing the performance of AI-driven variant curation to manual approaches\nReceive a virtual demonstration of how HGMD presents mutation data\, including how the database provides genomic coordinates\, Human Genome Variation Society (HGVS) nomenclatures for variants\, citations from key publications\, and where a variant is described in a paper or supplemental text\nLearn how HGMD simplifies literature review and supports CNV interpretation\nReceive a complimentary 5-day trial of HGMD Professional
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/can-you-trust-ai-for-germline-variant-curation-a-stanford-university-case-study/
CATEGORIES:Clinical,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230404T130000
DTEND;TZID=America/New_York:20230404T143000
DTSTAMP:20260404T041930
CREATED:20230307T180301Z
LAST-MODIFIED:20241024T182844Z
UID:10000613-1680613200-1680618600@staging.digitalinsights.supremeclients.com
SUMMARY:New user training: Large dataset analysis and knowledge base queries using QIAGEN Ingenuity Pathway Analysis (IPA)
DESCRIPTION:Join us for a 90-minute training session for new users of QIAGEN IPA. \nIn this training\, you’ll learn how to:\n• Upload your dataset (RNA-seq\, scRNA-seq\, proteomics\, metabolomics and more) and perform interactive core/pathway analysis in IPA\n• Understand the different result types produced (pathways\, key regulators\, impact on biological functions/diseases and more)\n• Compare different experimental conditions (treatments\, time points\, single-cell clusters\, disease types and more) and identify similarities and contrasts\n• Generate a network even without a dataset or experimental design for hypothesis generation \nFor those with IPA license\,\nTo install IPA before or after this training\, please use below installer.\nhttps://qiagen.showpad.com/share/CBv30blCPKFDUYHRWtAvI
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/new-user-training-large-dataset-analysis-and-knowledge-base-queries-using-qiagen-ingenuity-pathway-analysis-ipa-2/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230330T100000
DTEND;TZID=UTC:20230330T110000
DTSTAMP:20260404T041930
CREATED:20230329T123208Z
LAST-MODIFIED:20241024T182851Z
UID:10000627-1680170400-1680174000@staging.digitalinsights.supremeclients.com
SUMMARY:Accéder rapidement à une connaissance exhaustive pour l’interprétation des variants somatiques avec HSMD
DESCRIPTION:L’interprétation et la classification des variants somatiques demeurent un challenge alors que le nombre de gènes testés continue d’augmenter faisant apparaitre de nouvelles altérations. Ces nouveaux variants dont l’impact clinique est encore inconnu nécessitent une recherche d’information croisée à partir de nombreuses sources. Déterminer la classification d’un variant peut donc s’avérer longue et fastidieuse. La base de variants somatiques HSMD est une ressource en ligne qui vous permet rapidement et en toute confiance de classer vos nouveaux variants. En effet\, HSMD contient plus de 300 000 cas en oncologie clinique et plus de 1\,5 millions de mutations et leurs données associées\, manuellement capturées et intégrées dans la base de connaissance QIAGEN. Le profil mutationnel de gènes d’intérêt\, les gènes fréquemment mutés dans une pathologie donnée\, l’actionnabilité d’un gène ou encore les essais cliniques pour un cancer ou un traitement spécifique sont des requêtes que les utilisateurs d’HSMD peuvent effectuer simplement. Vous découvrirez lors de ce webinaire comment utiliser HSMD pour votre routine clinique ou dans un cadre de recherche translationnelle.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/acceder-rapidement-a-une-connaissance-exhaustive-pour-linterpretation-des-variants-somatiques-avec-hsmd/
CATEGORIES:Clinical,Training
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230323T130000
DTEND;TZID=America/New_York:20230323T143000
DTSTAMP:20260404T041930
CREATED:20230307T163759Z
LAST-MODIFIED:20241024T182839Z
UID:10000607-1679576400-1679581800@staging.digitalinsights.supremeclients.com
SUMMARY:Multi-omics (metabolomics\, proteomics\, transcriptomics) analysis using QIAGEN Ingenuity Pathway Analysis
DESCRIPTION:This 90-minute training session is about how QIAGEN Ingenuity Pathway Analysis (IPA) allows visualization of molecular intricacy and variations at multiple levels such as transcriptome\, proteome\, and metabolome. Through a series of brief technical vignettes\, it is demonstrated how to: \n· Generate associations among molecular signatures obtained via integrating multi-omics data \n· Extract mechanisms from multi-omics data for precision medicine \n· Disease stratification based on multi-omics profiles \n· Map disease networks among targets and indications \n  \nClick here to register.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/multi-omics-metabolomics-proteomics-transcriptomics-analysis-using-qiagen-ingenuity-pathway-analysis-3/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230323T110000
DTEND;TZID=America/New_York:20230323T120000
DTSTAMP:20260404T041930
CREATED:20230309T161946Z
LAST-MODIFIED:20241024T182845Z
UID:10000614-1679569200-1679572800@staging.digitalinsights.supremeclients.com
SUMMARY:How to simplify somatic NGS analysis & reduce literature review time by 90% with HSMD
DESCRIPTION:Across clinical oncology applications\, from molecular testing to cancer research\, the ability to identify potentially actionable genomic and genetic alterations to exploit the molecular vulnerabilities of cancer is a burgeoning field. Due to the sporadic nature of somatic cancers and the expansion of next-generation sequencing\, the number of variants detected through tumor testing is growing exponentially\, presenting a challenge to clinical cancer genetics professionals working to confidently identify meaningful mutations that could influence decision-making at point-of-care.\n\nJoin Chelsea Alexander\, a certified genetic counselor\, and Aarthi Goverdhan\, our lead oncology application development scientist\, for a live webinar on Thursday\, March 23rd at 11 AM EST to discover a new database that can streamline your somatic NGS analysis and significantly reduce your literature review time—by up to 90%!\n\nIn this webinar\, we will introduce you to the Human Somatic Mutation Database (HSMD)—a new somatic database developed by QIAGEN that contains extensive genomic content relevant to solid tumors and hematological malignancies. Available as a web-based application\, this expert-curated resource contains data from over 419\,000 real-world clinical oncology cases combined with insights from the QIAGEN Knowledge Base\, providing clinically observed variant frequencies across diseases\, and diving deep into gene-level\, alteration-level and disease-level information. Users can easily search and explore mutational characteristics across genes\, synthesize key findings from drug labels and professional guidelines\, explore clinical trials\, and receive detailed annotations for each observed variant. In addition\, users can interrogate a bibliography of over 170\,000 PubMed articles and access detailed alteration-specific summaries written by PhD scientists.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/how-to-simplify-somatic-ngs-analysis-reduce-literature-review-time-by-90-with-hsmd/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Clinical,Webinar
ATTACH;FMTTYPE=image/png:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/EmailHeader_LabrootsWebinarHSMD_0223_16x9_round.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230322T120000
DTEND;TZID=UTC:20230322T130000
DTSTAMP:20260404T041930
CREATED:20230310T075449Z
LAST-MODIFIED:20241024T182845Z
UID:10000615-1679486400-1679490000@staging.digitalinsights.supremeclients.com
SUMMARY:Lowering NGS analysis cost at lightspeed
DESCRIPTION:Advances in next-generation sequencing (NGS) technologies over the years have significantly decreased the cost of whole genome (WGS) and whole exome (WES) applications\, such that they are considered the standard of care within multiple healthcare organizations. Arguably\, the most significant NGS challenges lie within data analysis and interpretation. Various parameters such as sensitivity\, specificity\, cost and speed are critical for secondary analysis\, while accurate\, comprehensive and up-to-date content is required for reliable interpretation. These aspects are crucial\, especially where rapid turnaround times are critical for improved health outcomes. There is no better example than the implementation of WES and WGS in the neonatal and pediatric intensive care units (NICU/PICU). \nJoin this webinar to learn about QIAGEN CLC LightSpeed\, a secondary analysis software that dramatically reduces the cost and time it takes to analyze WES and WGS data and generate actionable insights. \nKey learning objectives \n\nLearn how to process FASTQ files to obtain quality variant calls in minutes\nDiscover how LightSpeed can be used on existing laptops\, desktops\, servers\, HPC or in the cloud\nLearn how LightSpeed will reduce your cost without sacrificing quality\nExplore how LightSpeed enables the fastest WES and WGS workflow from FASTQ to report\n\nWho should attend? \nBioinformaticians\, Geneticists\, Lab managers\, NGS technicians\, researchers\, and biologists
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/lowering-ngs-analysis-cost-at-lightspeed/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230316T130000
DTEND;TZID=America/New_York:20230316T143000
DTSTAMP:20260404T041930
CREATED:20230307T175844Z
LAST-MODIFIED:20241024T182844Z
UID:10000612-1678971600-1678977000@staging.digitalinsights.supremeclients.com
SUMMARY:IPA deeper dive: Generating novel discoveries in IPA - even when you don’t have data
DESCRIPTION:Take a deeper dive into the discovery capabilities of QIAGEN IPA. In this training\, you will learn how to:\n• Leverage the IPA knowledge base to generate hypotheses regarding novel biological mechanisms\, discover biomarkers and targets as well as design experiments.\n• Generate interactive networks using genes\, chemicals and diseases of interest\n• Search and interpret pathway analyses generated from public data (GEO\, SRA etc.)\n• Study gene or biomarker expression across different tissues\, diseases\, cell types and more from public sources\n• Correlate expression of genes across your biological condition of interest\n• Generate survival curves for cohorts generated based on expression or mutation status of a gene \nSpecific IPA analyses to be featured include:\n• Network construction (with and without data) • Activity Plot • Pattern Search • QIAGEN OmicSoft Land Explorer • Among others
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/ipa-deeper-dive-generating-novel-discoveries-in-ipa-even-when-you-dont-have-data/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230314T130000
DTEND;TZID=UTC:20230314T143000
DTSTAMP:20260404T041930
CREATED:20230307T172637Z
LAST-MODIFIED:20241024T182843Z
UID:10000609-1678798800-1678804200@staging.digitalinsights.supremeclients.com
SUMMARY:Biomarker discovery and disease pathology investigation using QIAGEN OmicSoft and Ingenuity Pathway Analysis
DESCRIPTION:In this training\, attendees will learn how to harness curated ‘omics datasets in OmicSoft DiseaseLand and curated research findings in IPA to discover new potential biomarkers. Using a neurological disorder as a case study\, we will:\n• Search public RNA-Seq datasets for tissue- and disease-specific differential expression in brain\n• Identify genes whose expression correlates with our factor within a sample group\n• Prioritize candidate biomarkers by disease vs. normal expression\n• Simulate biomarker activity changes to determine potential mechanisms of action\nInvestigation of inflammatory\, infectious\, oncological\, and other disorders can also be done using similar approach and will be highlighted during this training. \n  \nClick here to register.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/biomarker-discovery-and-disease-pathology-investigation-using-qiagen-omicsoft-and-ingenuity-pathway-analysis-2/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230312T000000
DTEND;TZID=UTC:20230312T235900
DTSTAMP:20260404T041930
CREATED:20230301T075831Z
LAST-MODIFIED:20241024T182832Z
UID:10000596-1678579200-1678665540@staging.digitalinsights.supremeclients.com
SUMMARY:Authenticated and reproducible cell line 'omics data
DESCRIPTION:Have you ever tried to access the genomic profiles of cell lines before using them in your preclinical experiments just to come up empty-handed? Maybe you’ve scoured public databases for gene expression information on your cell line to find the reported genomic profile doesn't match the cell line data you recently purchased? \nWe understand that knowing the genomic identity of your cell lines is fundamental to the success of your preclinical experiments. Unfortunately\, most publicly available sources have little or no cell line' omics data\, leaving you to fend for yourself. \nThat's why we've teamed up with ATCC\, the market leader in global biological materials and authenticated cell lines\, to deliver you manually curated cell line ‘omics data from the most popular cell lines offered by ATCC. We've collected this data into ATCC Cell Line Land\, our continually growing database of cell line 'omics data from both common and novel human and mouse cell lines\, primary tissues and cells from ATCC. ATCC Cell Line Land gives you access to standardized\, authenticated and reproducible cell line 'omics data characterizations which can be traced back to physical lots of cells in ATCC's biorepository. \nAttend our joint webinar with ATCC to learn about and explore ATCC Cell Line Land\, including: \n\nThe key limitations of public cell line data that drove its development\nHow we curate our data in the QIAGEN OmicSoft Lands framework\nWhy you can depend on the provenance of the data\nThe different types of 'omics data and metadata available\nHow it empowers you to plan and design your preclinical experiments more precisely\nHow to identify specific cell lines that express your gene of interest and those that don't\nHow to validate specific mutations from the literature\n\nWho should attend? Biologists\, preclinical researchers\, bioinformaticians\, data scientists \nClick here to register.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/authenticated-and-reproducible-cell-line-omics-data/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1108_8_QDI_CLC_Challenger_Or54963_16x9_56810_Large-1200px-2.jpg
ORGANIZER;CN="Test organizer 1":MAILTO:test@test.test
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230309T130000
DTEND;TZID=America/New_York:20230309T143000
DTSTAMP:20260404T041930
CREATED:20230307T174810Z
LAST-MODIFIED:20241024T182843Z
UID:10000610-1678366800-1678372200@staging.digitalinsights.supremeclients.com
SUMMARY:Isolate Typing\, Strain Identification and Anti-Microbial Resistance Analyses Using QIAGEN CLC Genomics Workbench
DESCRIPTION:QIAGEN CLC Genomics Workbench provides tools and workflows for a broad range of bioinformatics applications\, including microbiome analysis\, isolate characterization through SNP and K-mer trees using NGS data\, and antimicrobial resistance characterization. CLC Genomics Workbench is widely used for analyses of bacterial\, viral and eukaryotic (fungal) genomes and metagenomes. \nTopics covered in this webinar include: \nI. Overview of different tools within MGM application and research areas supported\nII. Focused review of isolate typing and characterization\na. Importing data\nb. Utilization of metadata\nc. Downloading and managing references\ni. Database of Isolates/ Resistances/ MLST\nd. Walk through of Type a Known Species workflow\ni. Review details for each Isolate\ne. Creating SNP profiles to specific reference\nf. Generate a SNP tree for isolate comparison\ng. Export tabular and high-quality graphical outputs in wide range of file formats \n  \nClick here to register.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/isolate-typing-strain-identification-and-anti-microbial-resistance-analyses-using-qiagen-clc-genomics-workbench/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230307T130000
DTEND;TZID=America/New_York:20230307T143000
DTSTAMP:20260404T041930
CREATED:20230307T175508Z
LAST-MODIFIED:20241024T182843Z
UID:10000611-1678194000-1678199400@staging.digitalinsights.supremeclients.com
SUMMARY:New user training: Large dataset analysis and knowledge base queries using QIAGEN Ingenuity Pathway Analysis (IPA)
DESCRIPTION:Join us for a 90-minute training session for new users of QIAGEN IPA. \nUsers will learn how to:\n• Upload their dataset (RNA-seq\, scRNA-seq\, proteomics\, metabolomics and more) and perform interactive core/pathway analysis in IPA\n• Understand the different result types produced (pathways\, key regulators\, impact on biological functions/diseases and more)\n• Compare different experimental conditions (treatments\, timepoints\, single-cell clusters\, disease types and more) and identify similarities and contrasts\n• Generate a network even without a dataset or experimental design for hypothesis generation \n 
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/new-user-training-large-dataset-analysis-and-knowledge-base-queries-using-qiagen-ingenuity-pathway-analysis-ipa/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230307T110000
DTEND;TZID=America/New_York:20230307T120000
DTSTAMP:20260404T041930
CREATED:20230307T171957Z
LAST-MODIFIED:20241024T182840Z
UID:10000608-1678186800-1678190400@staging.digitalinsights.supremeclients.com
SUMMARY:Comprehensive Molecular Tumor Analysis with Alacris Theranostics
DESCRIPTION:Join Dr. Marie-Laure Yaspo\, Co-Founder and Chief Scientific Officer of Alacris Theranostics\, as she discusses the development\, application\, and analysis of the Comprehensive Molecular Tumor Analysis (CMTA) test for cancer patients. \n\nPrecision oncology approaches have made great strides harnessing individual tumor mutation profiles to guide targeted therapy choices. However\, deeper molecular insights are needed to improve personalized treatment decisions. Integrating gene expression analysis in personalized oncology provides an additional level of insight. These analyses include evaluating expressed mutations and drug targets\, novel gene fusions\, clinically relevant signatures\, and the tumor immune microenvironment (TME). \nAlacris Theranostics developed the Comprehensive Molecular Tumor Analysis (CMTA)\, a NGS-based tumor diagnostic test. The test integrates whole exome and transcriptomic sequencing (WES and RNAseq). The test deploys as an end-to-end accredited diagnostic platform from tumor sample uptake (FFPE or frozen) to personalized clinical interpretation reports.  CMTA is a tumor-agnostic test that displays a unique molecular view of each sample. CMTA is a useful approach for refractory cancers with complex patterns or tumors of unknown origin. \nIn this webinar\, attendees will: \n\nLearn about the strategy implemented in Alacris’ bioinformatics pipeline to identify cancer-relevant somatic events\nLearn how Alacris uses QCI Interpret for Oncology to annotate variants and identify potential therapies\nBe eligible for a complimentary QCI Interpret demo and sample report\n\n 
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/comprehensive-molecular-tumor-analysis-with-alacris-theranostics-3/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Clinical,Webinar
ATTACH;FMTTYPE=image/png:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/230307_SoMe_BAN_QCI_Webinar_Alacris_16x9.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230302T130000
DTEND;TZID=America/New_York:20230302T143000
DTSTAMP:20260404T041930
CREATED:20230301T090150Z
LAST-MODIFIED:20241024T182838Z
UID:10000606-1677762000-1677767400@staging.digitalinsights.supremeclients.com
SUMMARY:Drug treatment\, toxicology and target safety assessment using QIAGEN IPA and OmicSoft
DESCRIPTION:In this 90-minute training\, you’ll learn how to do drug treatment\, toxicology and target safety assessment-related discoveries using QIAGEN Ingenuity Pathway Analysis (IPA) and QIAGEN Omicsoft Lands.\nUsing public data from GTEx (normal tissue)\, GEO\, cancer collections and more\, you’ll learn how to use Omicsoft Lands to:\n• Investigate a drug target or biomarker expression across different normal tissues\, disease conditions\, treatments and more\n• Correlate expression of two or more genes\n• Identify a list of genes or biomarkers specific to treatment\, disease\, normal tissue\, cell type and more \nUsing findings from peer-reviewed publications and other sources\, attendees we’ll explore with you how to use QIAGEN IPA to:\n• Study the impact of targeting a gene/protein on different toxicological and biological functions\n• Derive tox findings for a gene of interest from QIAGEN IPA’s knowledgebase\n• Identify and study toxicity-related pathways\, regulators and functions for an internal dataset or a public dataset\n• Compare different drug treatments\, other conditions or multi-omics data for novel discoveries \nClick here to register.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/drug-treatment-toxicology-and-target-safety-assessment-using-qiagen-ipa-and-omicsoft-2/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230222T130000
DTEND;TZID=UTC:20230222T130000
DTSTAMP:20260404T041930
CREATED:20230301T080935Z
LAST-MODIFIED:20241024T182833Z
UID:10000597-1677070800-1677070800@staging.digitalinsights.supremeclients.com
SUMMARY:IPA deeper dive: miRNA investigation using QIAGEN Ingenuity Pathway Analysis (IPA)
DESCRIPTION:In this 90-minute training session\, you will learn how to identify target mRNAs for your miRNAs of interest and associate them with pathways\, diseases\, biological functions\, tissues and cell types. \nTopics covered:\n- How to analyze miRNA-seq datasets alone\, or both miRNA and corresponding mRNA datasets together\n- How to use QIAGEN IPA without a dataset\, using miRNA IDs\n- Introduction to databases and curated content specific to miRNA\n- How to effectively apply various filters and functionalities to identify biomarkers\, key targets and novel biological mechanisms \nClick here to register.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/ipa-deeper-dive-mirna-investigation-using-qiagen-ingenuity-pathway-analysis-ipa/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230217T140000
DTEND;TZID=UTC:20230217T150000
DTSTAMP:20260404T041930
CREATED:20230301T081254Z
LAST-MODIFIED:20241024T182834Z
UID:10000598-1676642400-1676646000@staging.digitalinsights.supremeclients.com
SUMMARY:QIAGEN IPA deep-dive training\, Europe and Middle East
DESCRIPTION:Join us for a 90-minute training session to learn more about the advanced features of QIAGEN IPA \nUsers will learn how to:\n•Search across over 120\,000 analysed public datasets to find analyses of biological interest\n•Find experimental conditions that match a user’s data\n•Understand how to compare biological signatures and expression patterns of biomarkers across published studies
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/qiagen-ipa-deep-dive-training-europe-and-middle-east/
LOCATION:Virtual - EMEA - CET
CATEGORIES:Discovery,Training
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20221215T080000
DTEND;TZID=UTC:20221221T170000
DTSTAMP:20260404T041930
CREATED:20230301T082124Z
LAST-MODIFIED:20241024T182834Z
UID:10000599-1671091200-1671642000@staging.digitalinsights.supremeclients.com
SUMMARY:American Society of Human Genetics (ASHG)
DESCRIPTION:Forge lasting collaborations\, present emerging science\, and explore new tools & technologies that will transform your science and accelerate your career growth only at ASHG’s Annual Meeting.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/american-society-of-human-genetics-ashg/
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_9051_LS_Labo2019_SoMe_Email_881627278_16x9_46408_Large-1200px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20221110T080000
DTEND;TZID=UTC:20221125T170000
DTSTAMP:20260404T041930
CREATED:20230301T082750Z
LAST-MODIFIED:20241024T182834Z
UID:10000600-1668067200-1669395600@staging.digitalinsights.supremeclients.com
SUMMARY:3rd Annual Real-World Data\, Life Sciences Analytics and Market Access
DESCRIPTION:While the 2nd annual Congress had discussions on accelerating the adoption of Real-world Evidence within the industry while understanding the capabilities of newer technologies for evidence generation\, the 3rd Annual will focus on how the insights derived from real world data\, as well as acknowledgment of the effect the insights can have on improving decision making and patient consideration both internally and by regulators\, doctors\, and payers.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/3rd-annual-real-world-data-life-sciences-analytics-and-market-access/
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1250_7_QDI_QCI_GenQA_article_16x9-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221104
DTEND;VALUE=DATE:20221105
DTSTAMP:20260404T041930
CREATED:20230301T083632Z
LAST-MODIFIED:20241024T182835Z
UID:10000601-1667520000-1667606399@staging.digitalinsights.supremeclients.com
SUMMARY:ACGS Annual Meeting 2021
DESCRIPTION:The ACGS Organising Committee is looking forward to delivering an exciting programme to showcase the ACGS laboratory diagnostic community. The ACGS encourage participation by trainees and early career investigators from the UK and Ireland.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/acgs-annual-meeting-2021/
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1193_3_QDI_QDI_generic_4398_ATCC.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220529T010000
DTEND;TZID=UTC:20220529T143000
DTSTAMP:20260404T041930
CREATED:20230301T084646Z
LAST-MODIFIED:20241024T182835Z
UID:10000602-1653786000-1653834600@staging.digitalinsights.supremeclients.com
SUMMARY:Drug treatment\, toxicology and target safety assessment using QIAGEN IPA and OmicSoft
DESCRIPTION:In this 90-minute training\, you’ll learn how to do drug treatment\, toxicology and target safety assessment-related discoveries using QIAGEN Ingenuity Pathway Analysis (IPA) and QIAGEN Omicsoft Lands.\nUsing public data from GTEx (normal tissue)\, GEO\, cancer collections and more\, you’ll learn how to use Omicsoft Lands to:\n• Investigate a drug target or biomarker expression across different normal tissues\, disease conditions\, treatments and more\n• Correlate expression of two or more genes\n• Identify a list of genes or biomarkers specific to treatment\, disease\, normal tissue\, cell type and more \nUsing findings from peer-reviewed publications and other sources\, attendees we’ll explore with you how to use QIAGEN IPA to:\n• Study the impact of targeting a gene/protein on different toxicological and biological functions\n• Derive tox findings for a gene of interest from QIAGEN IPA’s knowledgebase\n• Identify and study toxicity-related pathways\, regulators and functions for an internal dataset or a public dataset\n• Compare different drug treatments\, other conditions or multi-omics data for novel discoveries \nClick here to register.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/drug-treatment-toxicology-and-target-safety-assessment-using-qiagen-ipa-and-omicsoft/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1109_2_QDI_CLC_Challenger_Or55151_16x9_56855_Large-1200px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220423T020000
DTEND;TZID=UTC:20220423T150000
DTSTAMP:20260404T041930
CREATED:20230301T085144Z
LAST-MODIFIED:20241024T182835Z
UID:10000603-1650679200-1650726000@staging.digitalinsights.supremeclients.com
SUMMARY:New user training Europe and Middle East: Large dataset analysis and knowledge base queries using QIAGEN IPA
DESCRIPTION:Join us for a 60-minute training session for new users of QIAGEN IPA. \nUsers will learn how to:\n• Upload their dataset (RNA-seq\, scRNA-seq\, proteomics\, metabolomics and more) and perform interactive core/pathway analysis in IPA\n• Understand the different result types produced (pathways\, key regulators\, impact on biological functions/diseases and more)\n• Compare different experimental conditions (treatments\, timepoints\, single-cell clusters\, disease types and more) and identify similarities and contrasts\n• Generate a network even without a dataset or experimental design for hypothesis generation
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/new-user-training-europe-and-middle-east-large-dataset-analysis-and-knowledge-base-queries-using-qiagen-ipa/
LOCATION:Virtual - EMEA - CET
CATEGORIES:Discovery,Training
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220330T010000
DTEND;TZID=UTC:20220330T140000
DTSTAMP:20260404T041930
CREATED:20230301T085402Z
LAST-MODIFIED:20241024T182837Z
UID:10000604-1648602000-1648648800@staging.digitalinsights.supremeclients.com
SUMMARY:QIAGEN CLC Main Workbench training
DESCRIPTION:Introduction to QIAGEN CLC Main Workbench\n• Alignment and tree construction\n• Sanger sequencing analysis\n• Cloning and primer design\n• Other molecular biology tools \nClick here to register.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/qiagen-clc-main-workbench-training/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
END:VEVENT
END:VCALENDAR